Evidence map›Paper›PMID 30755160›Full record

ArticleThe journal of headache and pain2019

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care.

Minna A Korolainen, Samu Kurki, Mariann I Lassenius, Iiro Toppila, Madlaina Costa-Scharplatz, Timo Purmonen, Markku Nissilä

Abstract read
In one paragraph

Article in The journal of headache and pain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Health equity, care access and quality in headache - part 2.The journal of headache and pain · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prevalence of Migraine in General Spanish Population; Factors Related and Use of Health Resources.International journal of environmental research and public health · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Minna A KorolainenNovartis Finland Oy, Espoo, Finland.
Samu KurkiTerveystalo Biobank Finland, Humalistonkatu 7B, 20100, Turku, Finland.
Mariann I LasseniusMedaffcon Oy, Espoo, Finland.
Iiro ToppilaMedaffcon Oy, Espoo, Finland.
Madlaina Costa-ScharplatzNovartis AB, Kista, Sweden.
Timo PurmonenNovartis Finland Oy, Espoo, Finland.
Markku NissiläTerveystalo Biobank Finland, Humalistonkatu 7B, 20100, Turku, Finland. Markku.Nissila@terveystalo.com.

Funding

Novartis Finland Oy not applicable
6 · The paper itself

Abstract

backgroundThe highest prevalence of migraine is detected among people who are of working age. The aim of this study was to assess the burden of migraine in an occupational health care setting using real world data collected as a part of routine clinical practice.

methodsThis retrospective register study included migraineurs using occupational health care at the private health care provider Terveystalo. An age and gender matched control population was established for comparison. Electronic medical records were assessed for overall and migraine related health care visits, sick-leaves and comorbidities. Stratification to acute and prophylactic treatment groups along with prophylactic treatment lines was based on prescriptions.

resultsAmong the 369,383 individuals in the study cohort, 7.4% women and 2.1% men were identified having a diagnosis of migraine. Prophylactic medication was prescribed to 13% of migraine patients and exclusively acute medication to 37%. Although migraine related visits and sick-leave days were significantly lower than overall visits or sick-leave days, both increased by prophylactic treatment line. The number of visits rose from 13.8 to 26.2 and sick-leave days from 16.8 to 30.4 per patient-year, in those without prophylaxis vs. ≥3 prophylactic treatments. Moreover, migraine patients had 1.7-fold increase in visits and 1.8-fold increase in sick leave days on average per patient-year, when compared to the control population. Depression and anxiety were 1.8-fold more common among patients with migraine, and the frequency also increase by treatment line.

conclusionsMigraine burden increased by each failed treatment line and was associated with increased comorbidity. In addition, migraine patients had significantly higher extent of visits and sick-leave days as well as extent of comorbidities when compared to their age- and gender-matched counterparts.

Indexed as

Cost of IllnessPatient Acceptance of Health CareAdolescentAdultAgedAnxiety DisordersCohort StudiesComorbidityDepressive DisorderFemaleFinlandFollow-Up StudiesHumansMaleMiddle AgedMigraine DisordersAbsenteeismComorbiditiesDisease burdenMigraineProphylactic treatmentTreatment lines

Identifiers

PMID30755160
PMCPMC6734482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.